Cabaletta Bio, Inc. (CABA)
2.36
-0.06
(-2.48%)
USD |
NASDAQ |
Dec 11, 16:00
2.365
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Cash from Investing (Quarterly): -50.08M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Verastem, Inc. | -8.279M |
| Anavex Life Sciences Corp. | 0.00 |
| Ocugen, Inc. | -0.086M |
| Cartesian Therapeutics, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.51M |
| Cash from Financing (Quarterly) | -0.806M |
| Free Cash Flow | -120.26M |
| Free Cash Flow Per Share (Quarterly) | -0.3382 |
| Free Cash Flow to Equity (Quarterly) | -35.47M |
| Free Cash Flow to Firm (Quarterly) | -34.00M |
| Free Cash Flow Yield | -76.89% |